The DOI matches its Crossref record; 84 of the 85 references it cites were found in a registry or an index.
Selective serotonin reuptake inhibitors: meta-analysis of efficacy and acceptability.
Open accessAbstract
OBJECTIVE--To examine the evidence for using selective serotonin reuptake inhibitors instead of tricyclic antidepressants in the first line treatment of depression. DESIGN--Meta-analysis of 63 randomised controlled trials comparing the efficacy and acceptability of selective serotonin reuptake inhibitors with those of tricyclic and related antidepressants. MAIN OUTCOME MEASURES--Improvement in mean scores on Hamilton depression rating scale for 53 randomised controlled trials. Pooled drop out rates from the 58 trials which reported drop out by treatment group. RESULTS--Among the 20 studies reporting standard deviation for the Hamilton score no difference was found in efficacy between serotonin reuptake inhibitors and tricyclic and related antidepressants (standardised mean difference 0.004, 95% confidence interval -0.096 to 0.105). The difference remained insignificant when the remaining 33 studies that used the 17 item and 21 item Hamilton score were included by ascribing weighted standard deviations. The odds ratio for drop out rate in patients receiving serotonin reuptake inhibitors compared with those receiving tricyclic antidepressants was 0.95 (0.86 to 1.07). Similar proportions in both groups cited lack of efficacy as the reason for dropping out but slightly more patients in the tricyclic group cited side effects (18.8% v 15.4% in serotonin reuptake group). CONCLUSIONS--Routine use of selective serotonin reuptake inhibitors as the first line treatment of depressive illness may greatly increase cost with only questionable benefit.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“while psychotropic medication has a role to play in treating mood disorders, it is not always effective, nor is it acceptable to many patients [12].”
From An exploratory mixed methods study of the acceptability and effectiveness of mindfulness -based cognitive therapy for patients with active depression and anxiety in primary care (2006) · cites this paper as [12]
Experimental — accuracy not yet measuredIn the citing paper
“A recent network meta-analysis for major depressive disorder showed that treatment discontinuation for mirtazapine is similar to placebo [15]”
From Pharmacological treatments for generalised anxiety disorder: A systematic review and network meta-analysis (2019) · cites this paper as [15]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817
Development of a Rating Scale for Primary Depressive Illness
Hamilton, M. (1967) · British Journal of Social and Clinical Psychology · doi:10.1111/j.2044-8260.1967.tb00530.x · Cited by 8,410
The combination of estimates from different experiments
Cochran, W. G. (1954) · Biometrics · doi:10.2307/3001666 · Cited by 5,380
Ostwald, P. F. (1960) · American Journal of Psychotherapy · doi:10.1176/appi.psychotherapy.1960.14.4.817 · Cited by 1,422
Recognition and management of depression in general practice: consensus statement
Paykel, E. S., & Priest, R. G. (1992) · BMJ · doi:10.1136/bmj.305.6863.1198 · Cited by 540
A comparison of statistical methods for combining event rates from clinical trials
Berlin, J. A., Laird, N. M., Sacks, H. S., & Chalmers, T. C. (1989) · Statistics in Medicine · doi:10.1002/sim.4780080202 · Cited by 418
Peto, R. (1987) · Statistics in Medicine · doi:10.1002/sim.4780060306 · Cited by 409
Danish University Antidepressant Group (1990) · Journal of Affective Disorders · doi:10.1016/0165-0327(90)90081-i · Cited by 398
Double-blind, multicenter comparison of sertraline and amitriptyline in elderly depressed patients.
Cohn, C. K., Shrivastava, R., Mendels, J., Cohn, J. B., Fabre, L. F., Claghorn, J. L., Dessain, E. C., Itil, T. M., & Lautin, A. (1990) · PubMed · Cited by 348
Research works printed but not linked: 2
- Sertraline for treatment of depression. Medical Letter on Drugs and Therapeutics 1992;34:47-8.
- Cohn JB, Crowder JE, Wilcox CS, Ryan PJ. A placeboand imipraminecontrolled study ofparoxetine. Psychopharmacol BuUl 1990;26:185-9.
Cited by
Sorted by citations
Items 301–398 of 398
Subject to many potential biases: TABLE
Gilbody, S. M., House, A. O., Song, F., & Sheldon, T. (1995) · BMJ · doi:10.1136/bmj.311.7015.1303c · Cited by 3
“updates our meta-analysis comparing drop out rates in patients taking selective serotonin reuptake inhibitors and tricyclic antidepressants”
MethodSelf-citationTallis, R. C. (1993) · The Lancet · doi:10.1016/0140-6736(93)90887-m · Cited by 3
Sandanapitchai, V., Ramasamy, S., & Pichai, E. (2016) · International Journal of Basic & Clinical Pharmacology · doi:10.18203/2319-2003.ijbcp20164122 · Cited by 3
Italian prescribing patterns in obsessive–compulsive disorder
Marazziti, D., Albert, U., Dell’Osso, B. M., Tundo, A., Cuniberti, F., Maina, G., Moroni, I., Benatti, B., Mucci, F., Massimetti, G., et al. (2017) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2641 · Cited by 4
“…of some studies showing that clomipramine is more effective than SSRIs in resistant patients [The Clomipramine Collaborative Study Group, 1991; Song et al., 1993; Danish University Antidepressant Group (DUAG), 1986; Danish University Antidepressant Group (DUAG), 1990], although current…”
ResultEffects of ABCB1 gene polymorphism on the efficacy of antidepressant drugs
Zheng, X., Fu, Z., Chen, X., Wang, M., & Zhu, R. (2021) · Medicine · doi:10.1097/md.0000000000026411 · Cited by 3
Nicht-trizyklische Antidepressiva
Laux, G., Delini‐Stula, A., Breyer-Pfaff, U., Demling, J. H., Ebert, D., Pöldinger, W., Kasper, S. F., Osterheider, M., Dietmaier, O., Möller, H., et al. (1993) · Springer eBooks · doi:10.1007/978-3-7091-3317-0_3 · Cited by 3
Bellantuono, C., & Balestrieri, M. (1995) · Epidemiologia e Psichiatria Sociale · doi:10.1017/s1121189x00010241 · Cited by 3
Effective and acceptable treatment for depression.
Foulds, R. (1993) · BMJ · doi:10.1136/bmj.306.6885.1125-a · Cited by 3
Effective and acceptable treatment for depression.
Cialdella, P. (1993) · BMJ · doi:10.1136/bmj.306.6885.1125 · Cited by 3
The new generation of antidepressants
Diab, T., & Singh, A. (2003) · Hospital Medicine · doi:10.12968/hosp.2003.64.1.1837 · Cited by 3
Treatment of major depression in psychiatric outpatient care: Position of new antidepressants
Sorvaniemi, M., Joukamaa, M. I., Helenius, H. Y. M., & Salokangas, R. K. R. (1997) · Nordic Journal of Psychiatry · doi:10.3109/08039489709090706 · Cited by 3
Selective serotonin reuptake inhibitors. Total profile of drug should be considered.
Ashford, J. J. (1994) · PubMed Central · Cited by 3
Efficacy and Effectiveness in the Antidepressant Treatment of Depression: Beyond Metaanalysis
Kennedy, S. H., & Bagby, R. M. (1996) · The Canadian Journal of Psychiatry · doi:10.1177/070674379604101001 · Cited by 3
“Drs Joffe and Sokolov, with noted expertise in the field of depression research, and Dr Streiner, with expertise in statistical methodology, have combined their respective academic strengths to respond to 2 previous reports, those of Greenberg and others (1) and Song and others (2), which brought into question the eff…”
BackgroundAntidepressants for anorexia nervosa
Claudino, A. M., Hay, P., Lima, M., Bacaltchuk, J., Schmidt, U. H., & Treasure, J. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004365 · Cited by 3
CONSUMO DE FÁRMACOS PSICOTRÓPICOS EM UMA FARMÁCIA BÁSICA DE CONGONHAS, MINAS GERAIS, BRASIL
Santos, M. E. R., Neves, N. C. V., Almeida, J. C. D. S., Amparo, T. R., Piau, A. V., & Rodrigues-das-Dôres, R. G. (2019) · Infarma - Ciências Farmacêuticas · doi:10.14450/2318-9312.v31.e4.a2019.pp285-292 · Cited by 2
S.04.08 Analysis of miRNome expression profiles in hippocampus of rats treated with antidepressants
Pelizzari, M., Tardito, D., Mallei, A., Corna, S., Treccani, G., Bocchio‐Chiavetto, L., Racagni, G., & Popoli, M. (2012) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(12)70129-3 · Cited by 2
Fleck, M. P., Berlim, M. T., Lafer, B., Sougey, É. B., Porto, J. A. D., Brasil, M. A. A., Juruena, M. F., & Hetem, L. A. (2009) · Cited by 2
Fleck, P. D. A., Lafer, B., Sougey, É. B., Porto, J. A. D., & Brasil, M. A. A. (2003) · Cited by 2
Review on Antidepressant Medication
Kaulage, S. R., Aldar, K. T., Jadhav, R. P., Jadhav, P. D., & Yadhav, V. D. (2019) · International Journal of Scientific Research in Science and Technology · doi:10.32628/ijsrst1962118 · Cited by 2
Rang, H. P., Dale, M. M., Ritter, J. M., Flower, R. J., & Henderson, G. (2012) · Elsevier eBooks · doi:10.1016/b978-0-7020-3471-8.00046-9 · Cited by 2
Rang, H. P., Dale, M. M., Ritter, J., & Flower, R. (2007) · Elsevier eBooks · doi:10.1016/b978-0-443-06911-6.50044-x · Cited by 2
Antidepressants for old people
Baldwin, R., Haddad, P. M., McAllister-Williams, H., Gordon, C., Livingston, M. G., & Livingston, H. M. (1999) · BMJ · doi:10.1136/bmj.319.7213.849b · Cited by 2
Automated Pharmacy Databases and Behavioral Health Care Quality Assurance
McFarland, B. H. (1997) · Evaluation Review · doi:10.1177/0193841x9702100312 · Cited by 2
“Even under the ideal circumstances of the randomized clinical trial, at least one third of subjects with major depressive disorder discontinue antidepressant medication because of adverse drug effects or failure to improve (Song et al. 1993).”
BackgroundA commentary: Measuring the health economics of depression
Eckett, S. (1995) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.470100106 · Cited by 2
Effective and acceptable treatment for depression.
Milne, S., Alcorn, A., & Bell, A. J. (1993) · BMJ · doi:10.1136/bmj.306.6885.1126-b · Cited by 2
Effective and acceptable treatment for depression: Authors' reply
Sheldon, T., Mason, J. M., Song, F., Freemantle, N., & House, A. O. (1993) · BMJ · doi:10.1136/bmj.306.6885.1126-c · Cited by 2
Self-citationExamining the effectiveness of treatments for depression in general practice
Sheldon, T., Freemantle, N., House, A. O., Adams, C. E., Mason, J. M., Song, F., Long, A., & Watson, P. (1993) · Journal of Mental Health · doi:10.3109/09638239309018397 · Cited by 2
Self-citationChoice of antidepressants by psychiatrists working with old people
Wattis, J. P., Bentham, P., & Bestley, J. (1994) · Psychiatric Bulletin · doi:10.1192/pb.18.3.148 · Cited by 2
Selective serotonin reuptake inhibitors. Methodology is inadequately described.
Puri, B. K., & Thakore, J. H. (1994) · PubMed Central · Cited by 2
Montgomery, S. (1995) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.470100902 · Cited by 2
Selective serotonin reuptake inhibitors. Authors' assumptions are misleading.
Brandt, A., & Bergemann, R. (1994) · PubMed Central · Cited by 2
Clozapine Drug-Drug Interactions: A Review of the Literature
EDGE, S. C., Markowitz, J. S., & DeVane, C. L. (1997) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/(sici)1099-1077(199701/02)12:1 · Cited by 46
Pharmacological Treatment of Suicidal Behavior
Schifano, F., & Leo, D. D. (1998) · Springer eBooks · doi:10.1007/0-306-47210-4_21 · Cited by 1
El futuro de la farmacoterapia antidepresiva
González-Ferreras, C. (2006) · Redalyc (Universidad Autónoma del Estado de México) · Cited by 1
Review: citalopram is effective and safe for depression
de Lima, M. S. (2001) · Evidence-Based Mental Health · doi:10.1136/ebmh.4.3.80 · Cited by 1
Ujeyl, M., & Müller-Oerlinghausen, B. (2012) · Der Schmerz · Cited by 1
Biological treatments of depression and anxiety
McGuffin, P., & FARMER, A. E. (2008) · Cambridge University Press eBooks · doi:10.1017/cbo9780511544125.028 · Cited by 1
McIntosh, A. M., Sussmann, J. E., & Goodwin, G. M. (2010) · Elsevier eBooks · doi:10.1016/b978-0-7020-3137-3.00016-4 · Cited by 1
Ma, J., Tang, X., Hu, Q., Wang, Q., Chen, Y., Li, X., Luo, T., & Cao, D. (2021) · Translational Cancer Research · doi:10.21037/tcr-20-2378 · Cited by 1
“To cross-compare all eligible interventions, NMAs for the outcomes of interest were conducted according to a Bayesian Markov chain Monte Carlo approach, as previously described (31), in WinBUGS version 1.”
MethodOutcomes in the Treatment of Major Depressive Disorder
Thase, M. E., & Koenig, A. M. (2009) · Medical psychiatry · doi:10.3109/9781420084887.002 · Cited by 1
Selektive Serotonin-Wiederaufnahmehemmer bei therapieresistenten und schweren Depressionen
Pfennig, A., Bauer, M., & Baethge, C. (2005) · Springer eBooks · doi:10.1007/3-540-28049-9_15 · Cited by 1
Developments in the evidence base in primary care psychiatry
Churchill, R. C., & McGuire, H. (1998) · International Review of Psychiatry · doi:10.1080/09540269874961 · Cited by 1
Evidence-based medicine and routine clinical practice: the case of new antidepressant drugs
Barbui, C. (2002) · Epidemiologia e Psichiatria Sociale · doi:10.1017/s1121189x00005650 · Cited by 1
“ANTIDEPRESSIVI DI VECCHIA E NUOVA GENERAZIONE: LE PROVE DI EFFICACIA Una delle piu note e influenti metanalisi nei campo degli AD e sicuramente quella portata a termine, quasi 10 anni fa, dal gruppo di Song et al. (1993).”
BackgroundDepressive Illness and the Possibilities of Somatic Antidepressant Treatment
Mårtensson, B. (1996) · International Journal of Technology Assessment in Health Care · doi:10.1017/s0266462300010886 · Cited by 1
“The advantage of the SSRIs is the more favorable side effect profile, in particular the lack of anticholinergic and cardiotoxic effects and the increased safety when taken in overdose, although the superiority of the side-effect profile in comparison with that of the TCAs has also been discussed (115).”
BackgroundDunn, C. D. R., & Beswick, D. T. (1995) · International Journal of Pharmacy Practice · doi:10.1111/j.2042-7174.1995.tb00794.x · Cited by 1
How to appraise clinical guidelines
Warner, J. P., & Blizard, R. (1998) · Psychiatric Bulletin · doi:10.1192/pb.22.12.759 · Cited by 1
“Although, these guidelines suggest SSRIs are better tolerated than tricyclic antidepressants, meta-analyses comparing discontinuation rates of these compounds have had differing conclu sions (Song et al 1993; Anderson & Tomenson.”
BackgroundConflict of interest: Sometimes consultancies cannot be disclosed
Garrow, J. S. (1994) · BMJ · doi:10.1136/bmj.308.6926.471a · Cited by 1
Utilization of two New Antidepressants, Fluvoxamine and Paroxetine, at a Psychiatric Clinic
Jacobson, N.-O., & Nawrin, J. (1994) · Nordic Journal of Psychiatry · doi:10.3109/08039489409078152 · Cited by 1
Deciding which selective serotonin reuptake inhibitor to prescribe
Cleare, A. J. (1995) · BMJ · doi:10.1136/bmj.311.7020.1641a · Cited by 1
“EDITOR,--Recent articles have debated the relative costs of selective serotonin reuptake inhibitors for depression in relation to their tolerability and efficacy.”
BackgroundMoncrieff, J. (1998) · Evidence-Based Mental Health · doi:10.1136/ebmh.1.1.21 · Cited by 1
Thakore, J. H., & John, D. (1996) · Europe PMC (PubMed Central) · Cited by 1
The clinical relevance of treatment with antidepressants
Nolen, W. A. (1995) · Acta Neuropsychiatrica · doi:10.1017/s092427080003756x · Cited by 1
“In a recent review Song et al.(7) performed a meta-analysis of 63 studies comparing SSRIs with TCAs and related compounds.”
Pharmacological Approaches to Behavioral Symptoms in Alzheimer's Disease
Galasko, D. (1996) · Informa Healthcare eBooks · doi:10.1201/9781420048407.ch21 · Cited by 1
Moffa, A. H. (2016) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.47.2016.tde-07102016-180727 · Cited by 1
Developing Serotonergic Antidepressants Acting on More Than the Serotonin Transporter
Marek, G. J. (2017) · Methods and principles in medicinal chemistry · doi:10.1002/9783527674381.ch12 · Cited by 1
Study did not consider treatment efficacy
Gram, L. F., Kragh-Sørensen, P., Isacsson, G., & Bergman, U. (1995) · BMJ · doi:10.1136/bmj.311.6996.55b · Cited by 1
Swinkels, J. A., Schene, A. H., & Wijers, J. H. L. (2001) · Bohn Stafleu van Loghum eBooks · doi:10.1007/978-90-313-7308-6_44 · Cited by 1
Hoes, M. J. A. J. M. (1994) · Acta Neuropsychiatrica · doi:10.1017/s0924270800033676 · Cited by 1
Meta-analysis of antidepressant prescribing
Freemantle, N., & Mason, J. M. (1995) · BMJ · doi:10.1136/bmj.311.7007.751 · Cited by 1
“The authors state that the newer second generation antidepressants in the tricyclic group included in our previous analysis”
BackgroundSelf-citationAcceptability of side effects as reason for stopping may bias results
Ramchandani, P. G., & Webb, V. (1995) · BMJ · doi:10.1136/bmj.311.7007.751b · Cited by 1
“The occurrence of side effects is only one of many factors affecting compliance, as the authors' analysis shows. Even with a difference in drop out rate of 25% between the classes of drug due to side effects, there was only a very small difference in the overall drop out rates. Other researchers have examined this are…”
ResultMonoamine Transporter Pathologies
Sealover, N. R., & Barker, E. L. (2010) · Advances in neurobiology · doi:10.1007/978-1-4419-7104-3_6
“of new classes of antidepressants, the effectiveness of these therapeutics remains no better than the MAOIs and patient compliance remains low (Song et al., 1993).”
BackgroundAntidepressant Use and Clinical and Economic Outcomes in a Primary Care Psychiatry Center in Spain
Crown, W. H., Hylan, T. R., Montejo, A. L., Sacristán, J. A., Gilaberte, I., & Meneades, L. M. (1999) · Springer eBooks · doi:10.1007/978-1-4615-4147-9_33
Ƶinner, D. E. (1996) · DSpace@MIT (Massachusetts Institute of Technology)
Kokkoli, E. (2013) · Electronic Theses of LMU Munich (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.16664
Implications of pharmaceutical cost controls for medical research
Doogan, D. P. (1968) · Irish Journal of Psychological Medicine · doi:10.1017/s0790966700012556
MacGillivray, S. A., Arroll, B., Hatcher, S., Ogston, S., Reid, I., Sullivan, F., & Colomer, M. E. B. (2003) · FMC - Formación Médica Continuada en Atención Primaria · doi:10.1016/s1134-2072(03)76072-1
Physical management of depression in the elderly
Menon, R. R., & Jacoby, R. J. (1993) · International Review of Psychiatry · doi:10.3109/09540269309037803
Improving prescribing practice
Donoghue, J. (1998) · International Review of Psychiatry · doi:10.1080/09540269874880
Studying new antidepressants: if there were a light at the end of the tunnel, could we see it?
Thase, M. E. (2002) · PubMed · Cited by 25
Reikvam, A.-G. (2010) · NORA - Norwegian Open Research Archives
Fluoxetineic Review of its Use in Depression
Bingefors, K., Donoghue, J., Edwards, J. G., Hotopf, M. H., & Mitchell, J. (1998)
Study's conclusion is unwarranted
Bernadt, M., & Hammill, R. (1995) · BMJ · doi:10.1136/bmj.311.6996.56
“In a meta-analysis selective serotonin reuptake inhibitors were significantly less efficacious than tricyclic antidepressants on the 17 item Hamilton depression rating scale, but the difference was clinically small.”
BackgroundPharmacological treatment strategies in mood, panic and obsessive compulsive disorders
Verhoeven, W. M. A., Tuinier, S., & Noten, J. B. G. M. (1996) · Acta Neuropsychiatrica · doi:10.1017/s092427080003725x
Outcomes in the Treatment of Major Depressive Disorder
Thase, M. E., & Koenig, A. M. (2009) · doi:10.3109/9781420084887-4
Human psychopharmacology of second generation antidepressants.
Fairweather, D. B. (1996) · Surrey Research Insight Open Access (The University of Surrey)
DEPRESSION ? AN EQUAL OPPORTUNISTIC KILLER.
Charak., A. (2018) · International Journal of Advanced Research · doi:10.21474/ijar01/8111
Holenz, J., Dı́az, J. L., & Buschmann, H. (2007) · Wiley eBooks · doi:10.1002/9783527619337.ch5
Lin, A. (2019) · Journal of Bioresource Management
Pal, R. S., Saraswat, N., Wal, P., Wal, A., Pal, Y., & Roohi, T. F. (2019) · Current Psychopharmacologye · doi:10.2174/2211556008666191019142247
Ocean acidification modulates the impact of fluoxetine on larval behaviors of non-target organisms
Chua, V. A. (2021) · Works - Scholarship, Research, & Creative Expression (Swarthmore College)
Laux, G. (2011) · Springer eBooks · doi:10.1007/978-3-642-03637-8_55
Laux, G. (2008) · Springer eBooks · doi:10.1007/978-3-540-33129-2_55
Pharmacoeconomic data support the use of SSRIs in depression
&NA; (2002) · Drugs & Therapy Perspectives · doi:10.2165/00042310-200218030-00009
(2007) · Prescriber · doi:10.1002/psb.6
Selektive Serotonin-Wiederaufnahmehemmer (SSRI) bei therapieresistenten und schweren Depressionen
Baethge, C., & Bauer, M. (1997) · Springer eBooks · doi:10.1007/978-3-662-10500-9_10
(2002) · CRC Press eBooks · doi:10.1201/noe1850709428.ch9
Joyce, D. A., & Ilett, K. F. (1994) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1994.tb127645.x
Review Article on Medicine Free Treatment and Prevention of Depression
Male, D. N., Vyawahare, S., Amle, V. S., P., A. R., & Pawar, V. (2025) · International Journal of Advanced Research in Science Communication and Technology · doi:10.48175/ijarsct-24904
Migraine, Psychiatric Disorders and Psychopharmacology
Bravo, M., Rueda-Lara, M. A., & Rosen, N. L. (2025) · Springer eBooks · doi:10.1007/978-3-031-86923-5_11
Treatment of Affective Disorders
Montgomery, S. (1996) · Springer eBooks · doi:10.1007/978-3-642-61076-9_13
Azé, O. D. (2019) · theses.fr (ABES) · doi:10.70675/98a87fe7z5da1z4bb9z92d3zb9dadc93cffe
Anderson, I. M., Nutt, D. J., & Deakin, J. F. W. (2000) · Journal of Psychopharmacology · doi:10.1177/026988110001400101 · Cited by 310
“…patients with major depression (Ia) Systematic reviews and meta-analyses suggest that the commonly available antidepressants have comparable efficacy in the majority of patients seen in primary care or outpatient psychiatric settings (Song et al., 1993; Anderson, 1997, 1999; Geddes et al., 1999).”
BackgroundSerotonin-selektive Antidepressiva(SSRI, DSA)
Laux, G., Eckert, A., Müller, W. E. G., Breyer-Pfaff, U., Kasper, S. F., Riedel, M. J., Müller, N., Möller, H., Hiemke, C., Schoechlin, C., et al. (2002) · Springer eBooks · doi:10.1007/978-3-7091-6150-0_4
Selective serotonin reuptake inhibitors and withdrawal symptoms: a review of the literature
Therrien, F., & Markowitz, J. S. (1997) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/(sici)1099-1077(199707/08)12:4
Holder (1998) · doi:10.1002/(sici)1099-176x(199803)1:1
Metadata
- Authors
- Song, F., Freemantle, N., Sheldon, T. A., House, A., Watson, P., Long, A., & Mason, J.
- Affiliations
- University of Leeds (GB)
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 1993-03-13
- Volume
- 306
- Issue
- 6879
- Pages
- 683-687
- ISSN
- 0007-1447 (ISSN-L)
- 0959-8138
- 1468-5833
- OpenAlex
- W2052223361
- Cited by
- 399
- References
- 85
- Citations by year
- 2025: 3 · 2023: 2 · 2021: 3 · 2019: 10 · 2018: 2 · 2017: 5 · 2016: 4 · 2015: 2 · 2014: 4 · 2013: 3 · 2012: 11
- FWCI
- 9.42
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.bmj.com/company/legal-information/terms-conditions/legal-information/tdm-licencepolicy (tdm)
- Locations
- BMJ (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Keywords
- selective serotonin reuptake inhibitors, tricyclic antidepressants, depression, treatment efficacy, treatment acceptability, treatment discontinuation, adverse effects, cost-effectiveness
- MeSH terms
- Antidepressive Agents, Tricyclic, Depressive Disorder, Humans, Patient Dropouts, Psychiatric Status Rating Scales, Randomized Controlled Trials as Topic, Treatment Outcome, Patient Satisfaction, Selective Serotonin Reuptake Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
